Reliability note

Titles and AI summaries are unofficial English monitoring aids, not legal advice or official translations. Each link opens the original Japanese official source, which remains authoritative.

Draft amendment to the Standards for Quasi-drug Ingredients 2021

医薬部外品原料規格2021を改正する件(案)に関する御意見の募集について

Published: 2026-10-30 · Source: e-Gov Public Comment · Stage: Public Comment Open · Area: Other · Impact (preliminary): Medium · Comment deadline: 2026-11-29 00:00 JST · First detected by this dashboard: 2026-10-30

View the original Japanese source Search all updates in the dashboard

AI summary

Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.

Summary

A draft amendment to the Standards for Quasi-drug Ingredients 2021 was published for public comment on 2026-10-30, with a stated deadline of 2026-11-29 00:00 JST. The listed contact is the Pharmaceutical Evaluation and Licensing Division of the Pharmaceutical Safety Bureau, Ministry of Health, Labour and Welfare.

Business Impact

Manufacturers of quasi-drugs and suppliers of quasi-drug ingredients may be affected by proposed changes to ingredient standards, but the metadata does not identify the ingredients or requirements concerned.

Recommended Action

Review of the official Japanese draft could clarify which ingredient standards would change and any proposed implementation arrangements.